VAXCYTE, INC. Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year
VAXCYTE, INC. (PCVX) had Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year of $5.98 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear · last filed 2026-08-05
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year $5.98M.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year $8.93M.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year $2.33M.
- 2025-06-30: Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year $5.27M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year |
|---|---|
| 2026-06-30 | $5.98M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $8.93M 10-Q · filed 2026-05-06 |
| 2025-09-30 | $2.33M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $5.27M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $8.21M 10-Q · filed 2025-05-07 |
| 2024-09-30 | $2.08M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $4.03M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $6.42M 10-Q · filed 2024-05-08 |
| 2020-09-30 | $183.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $363.00K 10-Q · filed 2020-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |